Bumper Offer - Urjas oil Just @ Rs. 1
Telmizem-Ch is an allopathic medicine The correct dosage of Telmizem-Ch depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Telmizem-Ch is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Telmizem-Ch is used -
Severe
Mild
Common
Is the use of Telmizem-Ch safe for pregnant women?
Telmizem-Ch shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Telmizem-Ch safe during breastfeeding?
Breastfeeding women can take Telmizem-Ch as it bears very minor side effects for them.
What is the effect of Telmizem-Ch on the Kidneys?
Telmizem-Ch is not harmful for kidneys.
What is the effect of Telmizem-Ch on the Liver?
Very few cases of side effects of Telmizem-Ch on the liver have been reported.
What is the effect of Telmizem-Ch on the Heart?
Telmizem-Ch is rarely harmful for the heart.
Telmizem-Ch should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmizem-Ch unless your doctor advises you to do so -
Is this Telmizem-Ch habit forming or addictive?
No, you will not get addicted to Telmizem-Ch.
Interaction between Food and Telmizem-Ch
Taking Telmizem-Ch with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Telmizem-Ch
Consult your doctor before consuming alcohol while taking Telmizem-Ch as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)